Table.
Important outcomes | Disease progression | ||||||||
Studies (Participants) | Outcome | Comparison | Type of evidence | Quality | Consistency | Directness | Effect size | GRADE | Comment |
What are the effects of treatment for primary acute angle-closure glaucoma? | |||||||||
1 (48) | Disease progression | Surgical treatment (any type) versus laser treatment (iridotomy or iridoplasty) | 4 | –2 | 0 | 0 | 0 | Low | Quality points deducted for sparse data and incomplete reporting of results |
What are the effects of treatment for primary chronic angle-closure glaucoma? | |||||||||
1 (126) | Disease progression | Laser peripheral iridoplasty plus laser peripheral iridotomy versus laser peripheral iridotomy alone | 4 | –2 | 0 | 0 | 0 | Low | Quality points deducted for sparse data and weak methods (blinding, outcome assessment, follow-up) |
We initially allocate 4 points to evidence from RCTs, and 2 points to evidence from observational studies. To attain the final GRADE score for a given comparison, points are deducted or added from this initial score based on preset criteria relating to the categories of quality, directness, consistency, and effect size. Quality: based on issues affecting methodological rigour (e.g., incomplete reporting of results, quasi-randomisation, sparse data [<200 people in the analysis]). Consistency: based on similarity of results across studies. Directness: based on generalisability of population or outcomes. Effect size: based on magnitude of effect as measured by statistics such as relative risk, odds ratio, or hazard ratio.